Skip to content

Aromaterapia inalatória com lavanda para redução da ansiedade

Pilot study for clinical application protocol of inhaled aromatherapy with lavender for anxiety reduction: a randomized double-blind placebo-controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3hf6gyw
Enrollment
Unknown
Registered
2025-03-18
Start date
2022-08-08
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety

Interventions

This study consists of a double-blind randomized controlled clinical trial. This design is defined as an experimental study that analyzes the effect of an intervention on human beings. Participants wi
physiological measures (blood pressure and oxygen saturation), and biomarkers (salivary cortisol and alpha amylase). This protocol with lavender EO is expected to be effective in reducing state-trait

Sponsors

Universidade Federal da Paraíba
Lead Sponsor
Universidade Federal da Paraíba
Collaborator

Eligibility

Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: Age between 18 and 30 years; with an anxiogenic trait and medium anxiety state (with scores between 30 and 39 on the State-Trait Anxiety Inventory/ STAI); who smell odors.

Exclusion criteria

Exclusion criteria: Being chemically dependent, or using anxiolytics, antidepressants, antihistamines, narcotics; being allergic to odors/smells, or undertaking some other complementary therapy for stress/anxiety relief such as meditation or yoga; People who meet the diagnostic criteria for Generalized Anxiety Disorder, Obsessive Compulsive Disorder, Major Depressive Disorder and Attention Deficit Disorder, according to the Structured Clinical Interview for Disorders screening strategy of DSM-5.

Design outcomes

Primary

MeasureTime frame
Decreased anxiety scores.

Secondary

MeasureTime frame
Decreased levels of cortisol in the urine; increase in sleep quality scores and decrease in stress and depression scores; Change in physiological parameters (blood pressure, heart rate variability and oxygen saturation).

Countries

Brazil

Contacts

Public ContactCentro de Ciências Humanas, Letras e Artes

Universidade Federal da Paraíba

humanas@cchla.ufpb.br(83) 3216-7330

Outcome results

None listed

Source: REBEC (via WHO ICTRP)